(Q34023578)

30 July 2017

7 references

13 March 2019

19 March 2019

24 March 2019

17 June 2019

20 August 2019

12 September 2019

4 December 2020

Drug mechanisms to help in managing resistant hypertension in obesity (English)

1 reference

30 July 2017

6 references

13 March 2019

19 March 2019

24 March 2019

17 June 2019

20 August 2019

12 September 2019

arterial hypertension

6 references

13 March 2019

19 March 2019

24 March 2019

17 June 2019

20 August 2019

12 September 2019

physiological phenomenon

1 reference

20 August 2019

1 reference

12 September 2019

antihypertensive drug

1 reference

4 December 2020

Wilko Spiering

3

0 references

author name string

Pieter M Jansen

series ordinal

1

1 reference

30 July 2017

Jan A H Danser

series ordinal

2

1 reference

30 July 2017

Anton H van den Meiracker

series ordinal

4

1 reference

30 July 2017

publication date

1 August 2010

8 references

Current Hypertension Reports

30 July 2017

13 March 2019

19 March 2019

24 March 2019

17 June 2019

20 August 2019

12 September 2019

4 December 2020

8 references

30 July 2017

13 March 2019

19 March 2019

24 March 2019

17 June 2019

20 August 2019

12 September 2019

4 December 2020

12

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

220-225

1 reference

Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Aldosterone-receptor antagonism in hypertension

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

European Society of Hypertension Working Group on Obesity: background, aims and perspectives.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Low-dose spironolactone in the management of resistant hypertension: a surveillance study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Effect of antihypertensive agents on the development of type 2 diabetes mellitus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Obesity and hypertension: two epidemics or one?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Tissue-specific nutritional regulation of angiotensinogen in adipose tissue

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients

28 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-010-0123-5

Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-010-0123-5

Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Efficacy of spironolactone therapy in patients with true resistant hypertension.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Aldosterone-to-renin ratio as a screening test for primary aldosteronism--the Dutch ARRAT Study

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Direct Renin inhibition with aliskiren in obese patients with arterial hypertension

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Association of adrenal steroids with hypertension and the metabolic syndrome in blacks

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Hemodynamic and metabolic responses to valsartan and atenolol in obese hypertensive patients

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Nongenomic effects of aldosterone in the human heart: interaction with angiotensin II.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Is there a rationale for angiotensin blockade in the management of obesity hypertension?

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

The kidney, hypertension, and obesity

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

The role of spironolactone in the treatment of patients with refractory hypertension

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Body mass index and the prevalence of hypertension and dyslipidemia

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Prospective study of the association between sleep-disordered breathing and hypertension

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Differential Control of Systolic and Diastolic Blood Pressure

29 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11906-010-0123-5

Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2910885

Renal denervation attenuates the sodium retention and hypertension associated with obesity

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20532698

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Efficacy of Add-On Aldosterone Receptor Blocker in Uncontrolled Hypertension

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20532698

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of spironolactone on blood pressure in subjects with resistant hypertension

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20532698

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11906-010-0123-5

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference